Liu Z, Huang S, Luo R, Shi X, Xiu M, Wang Y
Discov Oncol. 2025; 16(1):310.
PMID: 40074873
PMC: 11903978.
DOI: 10.1007/s12672-025-02045-w.
Li Z, Lin X, Yang Y, Tian M, Zhang L, Huang F
Sci Rep. 2025; 15(1):4002.
PMID: 39893221
PMC: 11787328.
DOI: 10.1038/s41598-025-88126-w.
Wang J, Liu F, Heng J, Li G
Mamm Genome. 2024; 36(1):262-279.
PMID: 39718579
DOI: 10.1007/s00335-024-10092-x.
Yang H, Fouad S, Smith P, Bae E, Ji Y, Lan X
Sci Adv. 2024; 10(32):eado0636.
PMID: 39121215
PMC: 11313846.
DOI: 10.1126/sciadv.ado0636.
Zannini L, Cardano M, Liberi G, Buscemi G
Cell Mol Life Sci. 2024; 81(1):339.
PMID: 39120648
PMC: 11335261.
DOI: 10.1007/s00018-024-05380-3.
Exo1 cooperates with Tel1/ATM in promoting recombination events at DNA replication forks.
Galli M, Frigerio C, Colombo C, Casari E, Longhese M, Clerici M
iScience. 2024; 27(8):110410.
PMID: 39081288
PMC: 11284563.
DOI: 10.1016/j.isci.2024.110410.
Metabolomics Combined with Physiology and Transcriptomics Reveal the Response of to Key Metabolic Pathways and Its Degradation Mechanism during Subculture.
He H, Cao Z, Wang T, Tang C, Li Y, Li X
Antioxidants (Basel). 2024; 13(7).
PMID: 39061849
PMC: 11274122.
DOI: 10.3390/antiox13070780.
Chk2 homolog Mek1 limits exonuclease 1-dependent DNA end resection during meiotic recombination in Saccharomyces cerevisiae.
Krystosek J, Bishop D
Genetics. 2024; 228(1).
PMID: 39005070
PMC: 11373520.
DOI: 10.1093/genetics/iyae112.
Evolution of Prime Editing Systems: Move Forward to the Treatment of Hereditary Diseases.
Volodina O, Fabrichnikova A, Anuchina A, Mishina O, Lavrov A, Smirnikhina S
Curr Gene Ther. 2024; 25(1):46-61.
PMID: 38623982
DOI: 10.2174/0115665232295117240405070809.
EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression.
Wang Z, Chao Z, Wang Q, Zou F, Song T, Xu L
J Transl Med. 2024; 22(1):104.
PMID: 38279172
PMC: 10811948.
DOI: 10.1186/s12967-023-04822-z.
Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers.
Jacquet E, Chuffart F, Vitte A, Nika E, Mousseau M, Khochbin S
BMC Genomics. 2023; 24(1):463.
PMID: 37592220
PMC: 10436393.
DOI: 10.1186/s12864-023-09571-3.
FAM60A promotes osteosarcoma development and progression.
Sun Y, Man Y, Cheng J, Li J, Liu Y
Cancer Med. 2023; 12(16):17491-17503.
PMID: 37439040
PMC: 10501228.
DOI: 10.1002/cam4.6343.
Explore the dominant factor in prime editing via a view of DNA processing.
Xu Z, Ma D, Su H, Jia X, Li Y, Lu Y
Synth Syst Biotechnol. 2023; 8(3):371-377.
PMID: 37325180
PMC: 10265487.
DOI: 10.1016/j.synbio.2023.05.007.
Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases.
Alenezi W, Fierheller C, Serruya C, Revil T, Oros K, Subramanian D
Front Oncol. 2023; 13:1111191.
PMID: 36969007
PMC: 10030840.
DOI: 10.3389/fonc.2023.1111191.
Germline-related molecular phenotype in Metazoa: conservation and innovation highlighted by comparative transcriptomics.
Piccinini G, Milani L
Evodevo. 2023; 14(1):2.
PMID: 36717890
PMC: 9885605.
DOI: 10.1186/s13227-022-00207-3.
Development of multivariable risk signature based on four immune-related RNA-binding proteins to predict survival and immune status in lung adenocarcinoma.
You Q, Shen H
Transl Cancer Res. 2022; 11(8):2591-2606.
PMID: 36093548
PMC: 9459526.
DOI: 10.21037/tcr-22-698.
Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer.
Manils J, Marruecos L, Soler C
Cells. 2022; 11(14).
PMID: 35883600
PMC: 9316158.
DOI: 10.3390/cells11142157.
Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A mice.
Wang S, Lee K, Gray S, Zhang Y, Tang C, Morrish R
Nucleic Acids Res. 2022; 50(14):8093-8106.
PMID: 35849338
PMC: 9371890.
DOI: 10.1093/nar/gkac616.
Exploring Potential Regulatory Anesthetic Drugs Based on RNA Binding Protein and Constructing CESC Prognosis Model: A Study Based on TCGA Database.
Zheng Y, Meng X, Yang J
Front Surg. 2022; 9:823566.
PMID: 35449547
PMC: 9018109.
DOI: 10.3389/fsurg.2022.823566.
XPG: a multitasking genome caretaker.
Muniesa-Vargas A, Theil A, Ribeiro-Silva C, Vermeulen W, Lans H
Cell Mol Life Sci. 2022; 79(3):166.
PMID: 35230528
PMC: 8888383.
DOI: 10.1007/s00018-022-04194-5.